APA (7th ed.) Citation

Hsu, H., Wen, C., Tang, Y., Lin, R., Li, W., Hsu, W., & Wang, Y. (2005). Promoter Hypermethylation Is the Predominant Mechanism in hMLH1 and hMSH2 Deregulation and Is a Poor Prognostic Factor in Nonsmoking Lung Cancer. Clinical cancer research, 11(15), 5410-5416. https://doi.org/10.1158/1078-0432.CCR-05-0601

Chicago Style (17th ed.) Citation

Hsu, Han-Shui, Chiao-Kai Wen, Yen-An Tang, Ruo-Kai Lin, Wing-Yin Li, Wen-Hu Hsu, and Yi-Ching Wang. "Promoter Hypermethylation Is the Predominant Mechanism in HMLH1 and HMSH2 Deregulation and Is a Poor Prognostic Factor in Nonsmoking Lung Cancer." Clinical Cancer Research 11, no. 15 (2005): 5410-5416. https://doi.org/10.1158/1078-0432.CCR-05-0601.

MLA (9th ed.) Citation

Hsu, Han-Shui, et al. "Promoter Hypermethylation Is the Predominant Mechanism in HMLH1 and HMSH2 Deregulation and Is a Poor Prognostic Factor in Nonsmoking Lung Cancer." Clinical Cancer Research, vol. 11, no. 15, 2005, pp. 5410-5416, https://doi.org/10.1158/1078-0432.CCR-05-0601.